Asciminib Roll-over Study | MicrobiomeTrials← Back to trialsNCT04877522
Asciminib Roll-over Study
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2022-08-30Est. Completion: 2030-08-30
Enrollment target: 347 participants Locations- Michigan Med University of Michigan, Ann Arbor, Michigan, United States
- Memorial Sloan Kettering, New York, New York, United States
- Oregon Health Sciences University, Portland, Oregon, United States
- Texas Oncology, Dallas, Texas, United States
- Uni Of TX MD Anderson Cancer Cntr, Houston, Texas, United States
- Medical College of Wisconsin, Milwaukee, Wisconsin, United States
- Novartis Investigative Site, CABA, Buenos Aires, Argentina
- Novartis Investigative Site, Capital Federal, Argentina
- Novartis Investigative Site, Graz, Austria
- Novartis Investigative Site, Vienna, Austria
- Novartis Investigative Site, Rio de Janeiro, Rio de Janeiro, Brazil
- Novartis Investigative Site, São Paulo, São Paulo, Brazil
- Novartis Investigative Site, São Paulo, São Paulo, Brazil
- Novartis Investigative Site, Varna, Bulgaria
- Novartis Investigative Site, Montreal, Quebec, Canada
- Novartis Investigative Site, Chongqing, Chongqing Municipality, China
- Novartis Investigative Site, Guangzhou, Guangdong, China
Other microbiome trials you might be interested in
Disease/Condition Name Cancer-related Cognitive DysfunctionChronic Lymphocytic Leukemia (CLL)Chronic Myeloid Leukemia, BCR-ABL1 Positive
This study examines whether there are differences in brain health or well-being in patients receiving TKI therapy for le…
Rochester, United StatesEst. completion Feb 28, 2029
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
This phase I/II trial studies the best dose of sorafenib when given together with busulfan and fludarabine in treating p…
Houston, United StatesEst. completion Dec 31, 2027
Novartis Investigative Site, Zhengzhou, Henan, ChinaNovartis Investigative Site, Wuhan, Hubei, ChinaNovartis Investigative Site, Changchun, Jilin, ChinaNovartis Investigative Site, Xian, Shanxi, ChinaNovartis Investigative Site, Chengdu, Sichuan, ChinaNovartis Investigative Site, Beijing, ChinaNovartis Investigative Site, Beijing, ChinaNovartis Investigative Site, Shanghai, ChinaNovartis Investigative Site, Shenyang, ChinaNovartis Investigative Site, Tianjin, ChinaNovartis Investigative Site, Ostrava, Poruba, CzechiaNovartis Investigative Site, Brno, CzechiaNovartis Investigative Site, Copenhagen, DenmarkNovartis Investigative Site, Bordeaux, FranceNovartis Investigative Site, Lyon, FranceNovartis Investigative Site, Marseille, FranceNovartis Investigative Site, Nantes, FranceNovartis Investigative Site, Paris, FranceNovartis Investigative Site, Vandœuvre-lès-Nancy, FranceNovartis Investigative Site, Frankfurt am Main, Hesse, GermanyNovartis Investigative Site, Jena, Thuringia, GermanyNovartis Investigative Site, Berlin, GermanyNovartis Investigative Site, Kiel, GermanyNovartis Investigative Site, Milan, MI, ItalyNovartis Investigative Site, Roma, RM, ItalyNovartis Investigative Site, Naples, ItalyNovartis Investigative Site, Kobe, Hyōgo, JapanNovartis Investigative Site, Beirut, LebanonNovartis Investigative Site, George Town, Pulau Pinang, MalaysiaNovartis Investigative Site, Johor Bahru, MalaysiaNovartis Investigative Site, Kuala Selangor, MalaysiaNovartis Investigative Site, Monterrey, Nuevo León, MexicoNovartis Investigative Site, Khoudh, OmanNovartis Investigative Site, Katowice, PolandNovartis Investigative Site, Krakow, PolandNovartis Investigative Site, Warsaw, PolandNovartis Investigative Site, Wroclaw, PolandNovartis Investigative Site, Lisbon, PortugalNovartis Investigative Site, Porto, PortugalNovartis Investigative Site, Timișoara, RomaniaNovartis Investigative Site, Moscow, RussiaNovartis Investigative Site, Moscow, RussiaNovartis Investigative Site, Saint Petersburg, RussiaNovartis Investigative Site, Saint Petersburg, RussiaNovartis Investigative Site, Riyadh, Saudi ArabiaNovartis Investigative Site, Singapore, SingaporeNovartis Investigative Site, Uijeongbu-si, Gyeonggi-do, South KoreaNovartis Investigative Site, Busan, South KoreaNovartis Investigative Site, Jeollanam, South KoreaNovartis Investigative Site, Seoul, South KoreaNovartis Investigative Site, Santiago Compostela, A Coruna, SpainNovartis Investigative Site, Badalona, Barcelona, SpainNovartis Investigative Site, L'Hospitalet de Llobregat, Barcelona, SpainNovartis Investigative Site, Bilbao, Bizkaia, SpainNovartis Investigative Site, Santa Cruz, Santa Cruz De Tenerife, SpainNovartis Investigative Site, Barcelona, SpainNovartis Investigative Site, Barcelona, SpainNovartis Investigative Site, Madrid, SpainNovartis Investigative Site, Madrid, SpainNovartis Investigative Site, Madrid, SpainNovartis Investigative Site, Seville, SpainNovartis Investigative Site, Valencia, SpainNovartis Investigative Site, Taoyuan, TaiwanNovartis Investigative Site, Samsun, Atakum, Turkey (Türkiye)Novartis Investigative Site, London, United KingdomNovartis Investigative Site, Oxford, United KingdomNovartis Investigative Site, Hanoi, VietnamNovartis Investigative Site, Ho Chi Minh City, VietnamAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMDSTransplantation, Stem CellConditioning TherapySHR2554Azacytidine
This study was designed as a prospective, multicenter, open-label, randomized controlled trial. Eligible participants we…
Suzhou, ChinaEst. completion Jun 2029